LPL and hypertriglyceridemia: ANGPTL4 is known to inactivate LPL, which reduces triglycerides (TG) conversion to free fatty acids, leading to hypertriglyceridemia (Sukonina et al, 2006; Mattijssen & Kersten, 2012).